Anixa Biosciences Inc (ANIX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $88.65M
Last updated: Nov 17, 2026 at 4:15 PM ET
Anixa Biosciences Inc (ANIX) Stock Chart
Anixa Biosciences (ANIX) has a latest price of $2.55 on Nov 17, 2026, 53.3% below its 52-week high of $5.46. Its price fell 41.9% over the past 12 months. The month-end price fell 50.9% over the 10 years through Oct 2026, a compound annual decline of 6.9%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $6.35 in Oct 2016 and its lowest $0.67 in Aug 2017, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart ANIX with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for ANIX.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 25.7%, and over 6 months it fell 7.6%. The month-end price fell 1.3% over the 3 years through Oct 2026, a compound annual decline of 0.4%.
| Period | Change |
|---|---|
| 1 month | -4.5% |
| 3 months | -25.7% |
| 6 months | -7.6% |
| 12 months | -41.9% |
| 12 months, with dividends | -41.9% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -1.3% | -0.4% |
| 5 years | -34.6% | -8.1% |
| 10 years | -50.9% | -6.9% |
Price by Year
Its best calendar year was 2018, when the price rose 66.9%, and its weakest was 2017, when it fell 56.3%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $3.12 | 0.0% |
| 2025 | $3.12 | +34.5% |
| 2024 | $2.32 | -40.2% |
| 2023 | $3.88 | -8.7% |
| 2022 | $4.25 | +43.1% |
| 2021 | $2.97 | -3.3% |
| 2020 | $3.07 | -6.4% |
| 2019 | $3.28 | -16.8% |
| 2018 | $3.94 | +66.9% |
| 2017 | $2.36 | -56.3% |
Trading Range
The price is 11.1% below its 50-day average of $2.87 and 13.7% below its 200-day average of $2.96.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $2.55 | |
| 52-week high | $5.46 | -53.3% |
| 52-week low | $2.32 | +9.9% |
| 50-day average | $2.87 | -11.1% |
| 200-day average | $2.96 | -13.7% |
Price Risk
Over 3 years, its largest fall from a peak was 57.6%.
| Measure | Value |
|---|---|
| 1-year beta | 1.50 |
| Largest fall, 1 year | -55.0% |
| Largest fall, 3 years | -57.6% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About ANIX
What is ANIX's 1-year price change?
Anixa Biosciences's price fell 41.9% over the past 12 months. With dividends included, the 12-month total return was -41.9%.
What is ANIX's 5-year price change?
Anixa Biosciences's month-end price fell 34.6% over the 5 years through Oct 2026, a compound annual decline of 8.1%. These figures leave out dividends.
What is ANIX's 52-week high and low?
Anixa Biosciences's 52-week high is $5.46 and its 52-week low is $2.32. Its latest price of $2.55 on Nov 17, 2026 is 53.3% below the high.
What is ANIX's beta?
Anixa Biosciences's 1-year beta against the S&P 500 is 1.50, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 55.0%.
Is the ANIX chart free?
Yes. Advanced Charting for ANIX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
ANIX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors